Clinuvel Pharmaceuticals (CUV.AU) Q3 2023 Earnings

29AugConfirmed
Q1 2022
Q3 2022
Q1 2023
Q3 2023
0.11
0.2
0.28
0.37

Details

Expected EPS
0.37
Actual EPS
0.37
Surprise EPS
0
Surprise Percent
+0%

Description

Clinuvel Pharmaceuticals (CUV.AU) has reported earnings of 0.37 per share for Q3 2023.

0 Comments

Share your thoughts